Citrine Global Corp. (OTCQB: CTGL) Announced its Subsidiary Files Provisional Patent Application Targeting to Address Oral Cavity Side Effects Associated with the Use of Medicines, Treatments, Aging or an Unbalanced/Unhealthy Lifestyle

Stock Information for Citrine Global Corp

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Citrine Global Corp

Citrine Global Corp. (DBA SkyTech Orion Global Corp.) (CTGL) announces CEO Ora Elharar Soffer as a UVID 2025 keynote speaker and will showcase the SkyTech Replicator(TM) modular drone platform and SkyTech Center, Israel's UAV hub
Citrine Global Corp. (DBA SkyTech Orion Global Corp.) (OTCQB: CTGL) Participates at AUVSI Defense 2025 Held in Washington, D.C., Launching SkyTech Replicator(TM), A Revolutionary Modular Drone that Transforms into 4 Different Mission Drones
Citrine Global Corp. (DBA SkyTech Orion Global Corp.) (OTCQB: CTGL) today issued a shareholder update letter from the Company's Chairwoman and Chief Executive Officer, Ora Elharar-Soffer
Citrine Global Corp. (CTGL) Announces Binding Agreement to Acquire 51% of iBOT Israel Botanicals, a Revenue-Generating Nutritional Supplements' Company with Fast-Growing Potential
Citrine Global Corp. (CTGL) Signs MOU with MyPlant Bio, Specialized in Botanical Drug Development, to Acquire 55% of MyPlant's Shares against Citrine Global Shares
Citrine Global Corp. (OTCQB: CTGL) Files Provisional Patent Application for Balancing Side Effects
Citrine Global Corp. (OTCQB: CTGL) Announces Prof. Itamar Grotto, a World-Renowned Expert in Public Health, Joining the Company's Israeli Subsidiary Board of Directors, and Appointed as President of Green Vision Center Israel
Citrine Global CEO Issues Letter to Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.